The 20 analysts offering 1 year price forecasts for NOT have a max estimate of — and a min estimate of —.
Analyst rating
Based on 28 analysts giving stock ratings to NOT in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
Be warned
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
NOT EPS for the last quarter is 1.85 EUR despite the estimation of 1.74 EUR. In the next quarter EPS is expected to reach 1.76 EUR. Track more of NOVARTIS INC financials and stay on top of what is up with the company.
In the next quarter NOVARTIS INC revenue is expected to reach 12.53 B EUR. Check out NOVARTIS INC revenue and earnings and make informed decisions.
According to analysts, NOT price target is 111.14 EUR with a max estimate of 131.74 EUR and a min estimate of 89.29 EUR. Check if this forecast comes true in a year, meanwhile watch NOVARTIS INC stock price chart and keep track of the current situation with NOT news and stock market news.
We've gathered opinions of 28 analysts rating NOT stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.